Loading clinical trials...
Loading clinical trials...
A Prospective Evaluation of Open-angle Glaucoma Subjects on One Topical Hypotensive Medication Treated With Two Trabecular Micro-bypass Stents
The purpose of this study is to evaluate the intraocular pressure (IOP) lowering effect of two iStent devices in eyes of subjects with primary open-angle glaucoma
This study evaluates the safety and efficacy of two iStents implanted in primary open-angle glaucoma subjects
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
Yes
S.V. Malayan's Ophthalmology Centre
Yerevan, Armenia
Start Date
December 1, 2010
Primary Completion Date
July 1, 2016
Completion Date
December 1, 2016
Last Updated
December 18, 2017
40
ESTIMATED participants
iStent
DEVICE
Lead Sponsor
Glaukos Corporation
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions